Golden Meditech Holdings Limited reported audited consolidated earnings results for the year ended March 31, 2017. For the period, the company reported revenue from continuing operations of HKD 230,666,000 compared to HKD 281,558,000 a year ago. Loss from operations was HKD 312,168,000 compared to HKD 265,240,000 a year ago. Loss attributable to the company's equity shareholders was HKD 147,121,000 or 5.0 cents per basic share compared to HKD 686,512,000 or 29.1 cents per basic share a year ago. Loss attributable to the company's equity shareholders from continuing operations was HKD 436,770,000 or 14.7 cents per basic share compared to HKD 405,561,000 or 17.2 cents per basic share a year ago. Loss before taxation was HKD 459,921,000 against HKD 426,957,000 a year ago. Net cash generated from operating activities was HKD 491,170,000 against HKD 543,647,000 a year ago. Payments for purchase of property, plant and equipment was HKD 78,061,000 against HKD 158,671,000 a year ago.